Grusha Y O, Ismailova D S, Kochetkov P A, Andreeva N A
Research Institute of Eye Diseases, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Vestn Oftalmol. 2020;136(4. Vyp. 2):193-200. doi: 10.17116/oftalma2020136042193.
To evaluate the effectiveness of bony orbital decompression in patients with dysthyroid optic neuropathy (DON).
The study analyzed 255 patients with thyroid eye disease (TED) and bony orbital decompression. Those among them who had DON as an indication for surgery were investigated further. Patients underwent standard ophthalmological examination, computer perimetry, color vision assessment using Ishihara tables, relative afferent pupillary defect (RAPD), computed tomography (CT) of the orbit, and in some cases optical coherence tomography (OCT) of the optic nerve.
Final analysis included 31 patients (52 eyes). On 13 orbits, only lateral wall decompression was performed, and medial wall decompression was the only intervention in 7 orbits. In other cases, these techniques were performed either simultaneously - in 14 orbits, or alternately - in 18 orbits. In the postoperative period, all patients showed significant positive dynamics in terms of visual acuity, visual field, and proptosis. In all cases, decrease of the amount of orbital inflammation was observed. Exophthalmos significantly decreased after surgery and averaged 20.5±3.1 mm, which is 4.7 mm less than the initial one. All changes were statistically significant (<0.01).
Bony orbital decompression is an effective and safe treatment option for DON resistant to high doses of glucocorticoids. In the vast majority of cases, this intervention is the only way to improve and stabilize visual function in this severe category of patients.
评估眼眶减压术治疗甲状腺相关性视神经病变(DON)患者的有效性。
本研究分析了255例接受眼眶减压术的甲状腺眼病(TED)患者。对其中以DON作为手术指征的患者进行了进一步调查。患者接受了标准眼科检查、电脑视野检查、使用石原氏表进行色觉评估、相对性传入瞳孔障碍(RAPD)、眼眶计算机断层扫描(CT),部分患者还接受了视神经光学相干断层扫描(OCT)。
最终分析纳入31例患者(52只眼)。13个眼眶仅进行了外侧壁减压,7个眼眶仅进行了内侧壁减压。在其他病例中,这些技术要么同时进行——14个眼眶,要么交替进行——18个眼眶。术后,所有患者在视力、视野和眼球突出度方面均表现出显著的积极变化。所有病例均观察到眼眶炎症程度减轻。术后眼球突出度显著降低,平均为20.5±3.1mm,比初始值减少了4.7mm。所有变化均具有统计学意义(<0.01)。
眼眶减压术是治疗对高剂量糖皮质激素耐药的DON的一种有效且安全的治疗选择。在绝大多数情况下,这种干预是改善和稳定这类重症患者视觉功能的唯一方法。